Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study

OBJECTIVES: This study investigated the effects of dose step-down in patients with rheumatoid arthritis (RA) who achieved sustained disease control with baricitinib 4 mg once a day. METHODS: Patients who completed a baricitinib phase 3 study could enter a long-term extension (LTE). In the LTE, patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Takeuchi, Tsutomu, Genovese, Mark C, Haraoui, Boulos, Li, Zhanguo, Xie, Li, Klar, Rena, Pinto-Correia, Ana, Otawa, Susan, Lopez-Romero, Pedro, de la Torre, Inmaculada, Macias, William, Rooney, Terence P, Smolen, Josef S
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352419/
https://ncbi.nlm.nih.gov/pubmed/30194275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados